IDXX

IDEXX Laboratories, Inc.

Healthcare
567.44 -8.63 -1.50% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 44.76B
EV 45.14B
Shares Out 78.88M
Revenue (ttm) 4.45B
Net Income 1.10B
Beta —
P/E —
Forward P/E —
EPS (ttm) $13.59
P/S 10.17
P/B 29.04
P/FCF 41.71
P/C 37.35
EV/Sales 10.15
EV/EBITDA 29.03
ROA 32.35%
ROE 72.65%
ROIC 52.75%
Gross Margin 62.05%
Oper. Margin 31.63%
Profit Margin 24.63%
Debt/Eq 0.37
LT Debt/Cap 16.16%
Quick Ratio 0.62
Current Ratio 1.12
Book/sh 19.54
Cash/sh 2.52
Div Yield —
Div TTM —
Payout Ratio —
SMA20 2.42%
SMA50 2.22%
SMA200 -9.09%
Volume 535,569
Avg Volume 614.96K
Rel Volume 0.87
Perf Week 0.57%
Perf Month 0.95%
Perf Quarter -2.68%
Perf Half Y -17.29%
Perf YTD -16.12%
Perf Year 10.27%
Perf 3Y 4.53%
Perf 5Y -15.23%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

IDEXX Laboratories, Inc. is a global diagnostics and software company serving veterinary healthcare, water microbiology and livestock and poultry diagnostics markets. The company…

Name
IDEXX Laboratories, Inc.
Industry
Diagnostics & Research
CEO
Jonathan J. Mazelsky · President and Chief Executive Officer
Employees
—
IPO Date
2014-11-19
Phone
(207) 556-0300
Address
One IDEXX Drive, Westbrook, ME 04092
Website
www.idexx.com

Key Executives

Name Title FY Pay
Jay Mazelsky President and CEO (Current as of filing date) —
Annette Catino Chief Financial Officer —
Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary —
Michael G. Erickson, PhD Chief Innovation Officer and President, Companion Animal Group Diagnostics —
Jonathan J. Mazelsky President and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.